On October 11, 2021, the Company received two more registration certificates for medicines in the Republic of Azerbaijan:
– Atrakurium-Novo/Atracurium-Novo, 10 mg/ml Solution for injection 2,5 ml; 5 ml in vial №5 (1×5) in contour-cell packaging, in carton box, DV № 21-00999;
– Propofol-Novo, 10 mg/ml mulsion for solution 20 ml, in vial №5 (1×5) in contour-cell packaging, in carton box, 50 ml, in vial №1, in carton box, DV № 21-01000.